You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ledipasvir, sofosbuvir drug combination

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Hepatitis C, HIV Coinfection Trial in Aurora (TDF with a boosted protease inhibitor, TAF with a boosted protease inhibitor, TAF

Completed
Has Results
  • Hepatitis C
  • HIV Coinfection
  • TDF with a boosted protease inhibitor
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 21, 2021

Hepatitis C Trial in Tanta (Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a)

Completed
  • Hepatitis C
  • Tanta, Egypt
  • +1 more
Aug 1, 2020

Hepatitis C, Medication Adherence Trial in Greenville (Intensive Models (mDOT and CGT) of HCV Care)

Completed
  • Hepatitis C
  • Medication Adherence
  • Intensive Models (mDOT and CGT) of HCV Care
  • Greenville, South Carolina
    Greenville Health System
Mar 26, 2021

The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry

Recruiting
  • Hepatitis C
  • Direct Acting Antivirals
  • Atlanta, Georgia
    The Taskforce for Global Health
May 6, 2022

Chronic Hepatitis C Trial in San Francisco (modified directly observed therapy (mDOT), unobserved dosing, Motivational

Completed
  • Chronic Hepatitis C
  • modified directly observed therapy (mDOT)
  • +2 more
  • San Francisco, California
    Substance Use Research Unit
Oct 20, 2020

HIV, Hepatitis C, Cirrhosis Trial in United States (Harvoni)

Completed
Has Results
  • HIV
  • +2 more
  • San Francisco, California
  • +7 more
Jan 12, 2021

Hepatitis C Trial (Zinc Supplement)

Not yet recruiting
  • Hepatitis C
  • Zinc Supplement
  • (no location specified)
Jul 16, 2022

Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)

Recruiting
  • Hepatitis C
  • HCV RNA Point of Care
  • +2 more
  • Sydney, New South Wales, Australia
    NUAA NSP
Aug 19, 2022

COVID-19 Trial in Mansoura (Sofosbuvir 400 MG plus Daclatasvir 200mg)

Unknown status
  • COVID-19
  • Sofosbuvir 400 MG plus Daclatasvir 200mg
  • Mansoura, Dakahlyia, Egypt
    Mansoura Faculty of Medicine
Feb 22, 2021

Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

Completed
  • Hepatitis C, Chronic
  • Opioid-use Disorder
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Aug 19, 2022

Hepatitis C Virus Infection Trial in Korea, Republic of (SOF/VEL, SOF/VEL/VOX)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Seongnam-si, Gyeonggi-D, Korea, Republic of
  • +21 more
Sep 29, 2021

Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)

Recruiting
  • Hepatitis C, Chronic
  • Pregnancy; Infection
  • Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
  • Denver, Colorado
  • +4 more
Dec 3, 2022

Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with

Completed
Has Results
  • Chronic Hepatitis C
  • SOF/LDV (sofosbuvir/ledipasvir)
  • +3 more
  • Little Rock, Arkansas
  • +37 more
Dec 1, 2021

HEPATITIS C, Virus, Human Immunodeficiency Trial in Aurora (Directly Observed Therapy, Wirelessly Observed Therapy)

Completed
  • HEPATITIS C
  • Virus, Human Immunodeficiency
  • Directly Observed Therapy
  • Wirelessly Observed Therapy
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Mar 4, 2022

HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],

Completed
Has Results
  • HCV Coinfection
  • +2 more
  • Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
  • Sofosbuvir/Velpatasvir (SOF/VEL)
  • Baltimore, Maryland
    Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
Feb 10, 2022

Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit

Unknown status
  • Antiviral Drug
  • (no location specified)
May 24, 2019

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Hepatitis C, Acute Hepatitis C Trial in Germany (Sofosbuvir and Velpatasvir)

Completed
  • Hepatitis C
  • Acute Hepatitis C
  • Sofosbuvir and Velpatasvir
  • Berlin-Friedrichshain, Germany
  • +13 more
Jul 2, 2021

COVID-19 Trial in Sao Paulo (Atazanavir, Daclatasvir 60 mg, Sofusbuvir + Daclastavir 60 mg)

Active, not recruiting
  • COVID-19
  • Sao Paulo, SP, Brazil
    Hospital do Coracao
Feb 25, 2022

Covid19 Trial in Cairo (Sofosbuvir plus Ledipasvir)

Completed
  • Covid19
  • Sofosbuvir plus Ledipasvir
  • Cairo, Egypt
    Almaza Military Fever Hospital
Aug 27, 2020

Insulin Resistance Trial in Geneva (Ledipasvir 90 mg/Sofosbuvir 400 mg, Ribavirin)

Completed
  • Insulin Resistance
  • Geneva, GE, Switzerland
    Division of Gastroenterology and hepatology, University Hospital
Apr 29, 2019

RIBAvirin Plasma COncentrations in Chronic Hepatitis C Infection

Completed
  • HCV Coinfection
  • Hepatitis C
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Centre
    Dec 4, 2020

    Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)

    Completed
    Has Results
    • Chronic Hepatitis C
    • Baltimore, Maryland
      Institute of Human Virology University of Maryland
    Apr 26, 2021